This enduring education aims to improve clinician’s knowledge and competence in identifying patients who would benefit and how to properly administer SC ICI to enhance long-term patient care. As a result of this educational activity, learners will be better able to: 1. Describe the rationale for SC ICI administration in the context of standard care with intravenous (IV) formulations in patients with advanced solid tumors; 2. Review the evidence for SC formulations of ICIs compared with IV formulations in patients with advanced solid tumors; and, 3. Propose patient-centered strategies for enhancing care with SC administration of ICIs in patients with advanced solid tumors. Learners have access to downloadable materials for future use in practice.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Pricing
99% of listed courses are free
156 of 157 courses listed here are free.
Collected from the provider’s public pages
Specialties served/covered
- Allergy & Clinical Immunology
- Anatomic & Clinical Pathology
- Cardiovascular Disease
- Communication & Shared Decision-Making
- Critical Care Medicine
- Dermatology
- Diagnostic Radiology
- Endocrinology, Diabetes & Metabolism
- Family Medicine
- Gastroenterology
- Gastrointestinal Surgery
- General Internal Medicine
- General Pediatrics
- General Surgery
- Gynecologic Oncology
- Hematology
- Infectious Disease
- Interventional Cardiology
- Maternal-Fetal Medicine
- Medical Oncology
- Nephrology
- Neurocritical Care
- Neurology
- Neuromuscular Medicine
- Obstetrics & Gynecology
- Ophthalmology
- Pediatric Gastroenterology
- Pediatric Infectious Diseases
- Pulmonary Disease
- Rheumatology
- Sleep Medicine
- Surgical Oncology
- Transplant Hepatology
- Urological Oncology
- Urology
- Vascular Neurology
- Cardio-Vascular
- Cross-Specialty
- Emergency & Critical Care
- GI & Liver
- Infectious Disease
- Internal Medicine
- Medical Subspecialties
- Neurology
- Ob/Gyn
- Oncology & Hematology
- Pathology & Lab
- Pediatrics
- Primary care
- Radiology
- Surgery
- Urology
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- Microlearning
- Credit · Up to 0.5 credits
- MOC · Up to 0.5 points
- Commercial Support
-
ReleasedMar 18, 2026
-
Last day to claim creditMar 18, 2027 5 months left
-
Efficient LLC +1 What Gets Under Patients Skin: Integrating Subcutaneous Immune Checkpoint Inhibitor Formulations into the Management of Solid Tumors in Oncology Practice
-
Creative Educational Concepts, Inc. Evolving Paradigms in Immuno-Oncology: Optimizing Patient Care Through Innovative Delivery Approaches of Immune Checkpoint Inhibitors
-
Medscape, LLC Collaborative Excellence in Cancer Care: A Multidisciplinary Approach to Integrating Subcutaneous Immunotherapy
-
Answers in CME Inc. (AiCME) Redefining Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: Are You Prepared?
-
Multiple Myeloma Research Foundation (MMRF) +1 Clinical Pearls for Subcutaneous Delivery: Optimizing Anti-CD38 Delivery in Multiple Myeloma
-
Answers in CME Inc. (AiCME) Translating Trials to Treatment: Practical Strategies for Immunotherapy Integration in Limited Stage- and Extensive Stage-SCLC
